During Thursday’s trading session, the shares of the company in the business of marketing & distribution of dental products slumped by 7.7 percent to Rs. 580.1 on NSE, despite reporting Q2 FY25 results with a rise in net profit by nearly 54 percent QoQ and 57.3 percent YoY.
With a market cap of Rs. 469.8 crores, the shares of Vasa Denticity Limited opened in the green at Rs. 380.7, as compared to its previous closing price of Rs. 362.6.
What’s the news:
The fluctuations in the share prices were observed after Vasa Denticity Limited announced the financial results for Q2 FY25, through the recent filings with the stock exchanges on Thursday during market hours.
For Q2 FY25, Vasa Denticity Limited reported revenue from operations of Rs. 58.3 crores, reflecting a significant growth of around 9 percent QoQ from Rs. 53.5 crores in Q1 FY25, and increased by about 43.2 percent YoY from Rs. 40.7 crores in Q2 FY24.
The company’s net profit for Q2 FY25 grew to Rs. 7.08 crores, representing a rise of around 54 percent QoQ from Rs. 4.6 crores in Q1 FY25, and a year-on-year growth of nearly 57.3 percent from Rs. 4.5 crores in Q2 FY24.
Shareholding Pattern:
As per the September 2024 shareholding pattern, the Promoters hold a 69.62 percent stake in the company, Foreign Institutional Investors (FII) hold a 0.02 percent stake, while Retail Investors and Domestic Institutional Investors (DII) hold a 30.13 percent and 0.23 percent stake in Vasa Denticity, respectively.
As per the September 2024 shareholding data available with the BSE, the ace investor Ashish Kacholia holds a 3.8 percent stake, while Mukul Mahavir Agrawal holds a 2.56 percent stake in Vasa Denticity.
About the company:
Incorporated in 2016, Vasa Denticity Limited is engaged in the business of marketing and distribution of a wide range of dental equipments.
The company’s shares were listed on the NSE SME exchange on 2nd June 2023 at a premium of 65% against its price band of Rs. 121-128 per equity share, and the stock opened at Rs. 211 per share.
Written by Shivani Singh
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
